ADAMA (000553) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
22 Dec, 2025Executive summary
Achieved stable or slightly increased sales in Q3 and over nine months, with Q3 sales up 2.4% to $853 million and nine-month sales stable at $2,698 million, while global crop protection demand recovered and channel inventories normalized.
Significant improvements in gross profit and EBITDA margins, driven by operational efficiency, cost controls, and the 'Fight Forward' transformation plan.
Net loss narrowed substantially year-over-year in Q3 and over nine months, with Q3 net loss down 63.69% and nine-month net loss down 77%.
Adjusted net income turned positive for the nine months, reflecting improved business quality and lower financial expenses.
Market demand is recovering, but pricing remains under pressure due to oversupply and low agricultural commodity prices.
Financial highlights
Q3 sales reached $853 million (up 2.4% YoY) and RMB 6.65 billion (up 0.62% YoY); nine-month sales stable at $2,698 million and RMB 21.68 billion (up 0.72%).
Q3 gross profit increased 18% to $242 million; Q3 adjusted gross profit rose 14% to $257 million; Q3 EBITDA up 59% to $97 million and RMB 742 million (up 87.42%).
Q3 adjusted net loss narrowed to $20 million from $78 million; Q3 net loss: RMB 342 million, improved from RMB 943 million.
Nine-month adjusted net income was $29 million versus a $149 million loss last year; nine-month net loss: RMB 423 million, improved from RMB 1.84 billion.
Operating cash flow for nine months: RMB 2.37 billion, down 17.06% YoY; free cash flow: $74 million for 9M.
Outlook and guidance
Management expects continued pricing pressure due to oversupply and high interest rates, but operational improvements and cost controls are expected to support margins.
The 'Fight Forward' transformation plan is credited with delivering consecutive quarters of EBITDA growth.
Latest events from ADAMA
- Margins and cash flow improved in Q3 2024 despite lower sales and ongoing pricing pressure.000553
Q3 20243 Feb 2026 - Sales fell 16% in H1 2024, but margins and cash flow improved through cost discipline.000553
Q2 202422 Jan 2026 - EBITDA and margins rose, net losses narrowed, and top-line growth returned despite price pressure.000553
Q2 202522 Dec 2025 - Returned to profit in Q1 2025 with improved margins amid ongoing market headwinds.000553
Q1 202522 Dec 2025 - Gross and EBITDA margins rose in 2024, with strong cash flow despite lower sales.000553
Q4 20243 Dec 2025